Harmony Biosciences
HRMY
HRMY
102 hedge funds and large institutions have $1.19B invested in Harmony Biosciences in 2021 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 31 increasing their positions, 30 reducing their positions, and 9 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
102
Holders Change
+18
Holders Change %
+21.43%
% of All Funds
1.79%
Holding in Top 10
6
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.11%
New
27
Increased
31
Reduced
30
Closed
9
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$74.3M |
| 2 |
Adage Capital Partners
Boston,
Massachusetts
|
+$47.5M |
| 3 |
Blackstone Inc
New York
|
+$40.2M |
| 4 |
VC
Vivo Capital
Palo Alto,
California
|
+$13.4M |
| 5 |
BlackRock
New York
|
+$11.9M |
Top Sellers
| 1 |
NHAS
Novo Holdings A/S
Hellerup,
Denmark
|
-$53M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
-$31.1M |
| 3 |
NP
Newlight Partners
New York
|
-$29.3M |
| 4 |
VP
venBio Partners
San Francisco,
California
|
-$16.9M |
| 5 |
ACM
Aisling Capital Management
New York
|
-$9.58M |
